ADM Stock Analysis: Archer-Daniels-Midland | NYSE
Farm Products | NYSE, USA | Market Cap: 37.009m USD | 12M Return: 43.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 271M
EPS Trend: -98.6%
Qual. Beats: 0
Rev. Trend: -97.7%
Qual. Beats: -2
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Archer-Daniels-Midland Company (ADM) is a global agribusiness that produces human and animal nutrition ingredients and solutions, operating in three main segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The companys operations span the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and other international markets, encompassing the origination, merchandising, transportation, and storage of agricultural raw materials, as well as the crushing and processing of oilseeds such as soybeans, cottonseed, sunflower, canola, rapeseed, and flaxseed. ADM also engages in corn and wheat wet and dry milling, producing distillers grains and corn gluten products for animal feed, while its Nutrition segment manufactures plant-based proteins, flavors, colors, emulsifiers, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, and botanical extracts for food and feed applications. The company is also involved in structured trade finance, carbon capture and sequestration initiatives, derivatives trading, and insurance coverage for various risks. Founded in 1902 and headquartered in Chicago, Illinois, ADM has been publicly traded since its 1983 IPO.
As a member of the dominant group of global agricultural commodity traders (often referred to as the ABCD companies alongside Bunge, Cargill, and Louis Dreyfus), ADM operates within the Consumer Staples sector, classified under Agricultural Products & Services, benefiting from relatively stable demand driven by food, feed, and biofuel end markets.
- Soybean crush margins track global supply and renewable diesel demand
- Nutrition segment margins expand on specialty ingredient pricing power
- Biofuel mandates and ethanol demand lift Carbohydrate Solutions revenue
| Net Income: 1.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 8.20 > 1.0 |
| NWC/Revenue: 8.83% < 20% (prev 9.20%; Δ -0.37% < -1%) |
| CFO/TA 0.11 > 3% & CFO 5.94b > Net Income 1.08b |
| Net Debt (11.4b) to EBITDA (3.90b): 2.91 < 3 |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (484.0m) vs 12m ago 0.21% < -2% |
| Gross Margin: 5.83% > 18% (prev 6.32%; Δ -0.49% > 0.5%) |
| Asset Turnover: 147.9% > 50% (prev 157.0%; Δ -9.13% > 0%) |
| Interest Coverage Ratio: 3.08 > 6 (EBIT TTM 1.86b / Interest Expense TTM 603.0m) |
| A: 0.13 (Total Current Assets 30.0b - Total Current Liabilities 22.9b) / Total Assets 55.6b |
| B: 0.40 (Retained Earnings 22.0b / Total Assets 55.6b) |
| C: 0.03 (EBIT TTM 1.86b / Avg Total Assets 54.5b) |
| D: 0.70 (Book Value of Equity 22.8b / Total Liabilities 32.5b) |
| Altman-Z'' = 3.10 = A |
| DSRI: 0.90 (Receivables 5.68b/6.58b, Revenue 80.6b/83.9b) |
| GMI: 1.08 (GM 6.32% / 5.83%) |
| AQI: 0.97 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 0.96 (Revenue 80.6b / 83.9b) |
| TATA: -0.09 (NI 1.08b - CFO 5.94b) / TA 55.6b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of July 04, 2026, the stock is trading at USD 76.79 with a total of 2,595,500 shares traded. Over the past week, the price has changed by +0.33%, over one month by -8.70%, over three months by +5.34% and over the past year by +43.21%.
Current recommended Stop Loss: 72.20 (which is 6% or 2.1 ATR below the current price).
Archer-Daniels-Midland has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold ADM.
- StrongBuy: 1
- Buy: 0
- Hold: 9
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 74.6 | -2.9% |
P/E Trailing = 34.2813
P/E Forward = 15.9744
P/S = 0.4593
P/B = 1.6229
P/EG = 2.3296
Revenue TTM = 80.6b USD
EBIT TTM = 1.86b USD
EBITDA TTM = 3.90b USD
Long Term Debt = 6.46b USD (from longTermDebt, last quarter)
Short Term Debt = 3.17b USD (from shortTermDebt, last quarter)
Debt = 12.0b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 11.4b USD (calculated: Debt 12.0b - CCE 624.0m)
Enterprise Value = 48.4b USD (37.0b + Debt 12.0b - CCE 624.0m)
Interest Coverage Ratio = 3.08 (Ebit TTM 1.86b / Interest Expense TTM 603.0m)
EV/FCF = 10.09x (Enterprise Value 48.4b / FCF TTM 4.79b)
FCF Yield = 9.91% (FCF TTM 4.79b / Enterprise Value 48.4b)
FCF Margin = 5.95% (FCF TTM 4.79b / Revenue TTM 80.6b)
Net Margin = 1.34% (Net Income TTM 1.08b / Revenue TTM 80.6b)
Gross Margin = 5.83% ((Revenue TTM 80.6b - Cost of Revenue TTM 75.9b) / Revenue TTM)
Gross Margin QoQ = 5.96% (prev 6.54%)
Tobins Q-Ratio = 0.87 (Enterprise Value 48.4b / Total Assets 55.6b)
Interest Expense / Debt = 5.03% (Interest Expense 603.0m / Debt 12.0b)
Taxrate = 15.71% (202.0m / 1.29b)
NOPAT = 1.57b (EBIT 1.86b * (1 - 15.71%))
Current Ratio = 1.31 (Total Current Assets 30.0b / Total Current Liabilities 22.9b)
Debt / Equity = 0.53 (Debt 12.0b / totalStockholderEquity, last quarter 22.8b)
Debt / EBITDA = 2.91 (Net Debt 11.4b / EBITDA 3.90b)
Debt / FCF = 2.37 (Net Debt 11.4b / FCF TTM 4.79b)
Total Stockholder Equity = 22.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.98% (Net Income 1.08b / Total Assets 55.6b)
RoE = 4.78% (Net Income TTM 1.08b / Total Stockholder Equity 22.6b)
RoCE = 6.39% (EBIT 1.86b / Capital Employed (Equity 22.6b + L.T.Debt 6.46b))
RoIC = 4.44% (NOPAT 1.57b / Invested Capital 35.3b)
WACC = 6.13% (E(37.0b)/V(49.0b) * Re(6.74%) + D(12.0b)/V(49.0b) * Rd(5.03%) * (1-Tc(0.16)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -40.90 | Cagr: -4.04%
[DCF] Terminal Value 77.97% ; FCFF base≈2.97b ; Y1≈3.40b ; Y5≈5.00b
[DCF] Fair Price = 132.6 (EV 75.3b - Net Debt 11.4b = Equity 63.9b / Shares 482.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -98.63 | EPS CAGR: -28.58% | SUE: 0.48 | # QB: 0
Revenue Correlation: -97.69 | Revenue CAGR: -7.53% | SUE: -1.00 | # QB: -2
EPS current Quarter (2026-06-30): EPS=1.34 | Chg30d=-4.62% | Revisions=+73% | Analysts=8
EPS next Quarter (2026-09-30): EPS=1.30 | Chg30d=+2.91% | Revisions=+36% | Analysts=8
EPS current Year (2026-12-31): EPS=4.67 | Chg30d=-0.39% | Revisions=+75% | GrowthEPS=+36.3% | GrowthRev=+6.8%
EPS next Year (2027-12-31): EPS=5.37 | Chg30d=+3.48% | Revisions=+58% | GrowthEPS=+14.9% | GrowthRev=+4.4%
[Analyst] Revisions Ratio: +76% (up=31, down=3)